Zivo Bioscience
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 |
|---|---|---|
Revenue | $65 | $53 |
Gross Profit | 21 | 17 |
EBITDA | -1,020 | -1,632 |
Net Income | -1,033 | -1,640 |
Net Change In Cash | 65 | 53 |
Free Cash Flow | -266 | -476 |
Cash | 57 | 9 |
Basic Shares | 3,817 | 3,810 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $119 | $157 | $27 | $4 |
Gross Profit | 39 | 48 | 11 | 0 |
EBITDA | -9,837 | -13,263 | -6,823 | -8,731 |
EBIT | -9,853 | -13,361 | -7,263 | -8,731 |
Net Income | -9,892 | -13,384 | -7,777 | -8,745 |
Net Change In Cash | 119 | 157 | 27 | 4 |
Free Cash Flow | -3,286 | -4,313 | -5,799 | -7,102 |
Cash | 67 | 1,542 | 274 | 1,799 |
Basic Shares | 3,820 | 3,410 | 1,690 | 1,569 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | -$0.27 |
2025-06-30 | -$0.43 |
2025-03-31 | -$1.12 |
2024-12-31 | -$0.36 |